Encapsulated EGCG maintained its biological activity, being able to inhibit hepatocyte growth factor (HGF) and subsequent activation of cell signaling pathways responsible for cell invasion in breast cancer cell line MDA-MD-23. This evidence concerns the gene HGF and breast carcinoma.